Circulating levels of endothelin and atrial natriuretic factor during postnatal life. 1992

T Kojima, and Y Isozaki-Fukuda, and M Takedatsu, and Y Hirata, and Y Kobayashi
Department of Pediatrics, Kansai Medical University, Osaka, Japan.

We determined plasma endothelin-1-like immunoreactivity and atrial natriuretic factor concentrations in preterm and full-term newborn infants during the first month of life. Plasma endothelin-1-like immunoreactivity levels were far greater than those of maternal blood in the newborn infants. The highest plasma endothelin-1-like immunoreactivity levels were observed on the first day of life (8.7 +/- 3.7 pmol/l) and gradually decreased with age. There was no significant difference in plasma endothelin-1-like immunoreactivity levels between preterm and full-term infants. A good correlation was observed between plasma endothelin-1-like immunoreactivity levels and atrial natriuretic factor concentrations (p < 0.01). These results suggest that circulating endothelin may regulate the cardiovascular system in the newborn period.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007234 Infant, Premature A human infant born before 37 weeks of GESTATION. Neonatal Prematurity,Premature Infants,Preterm Infants,Infant, Preterm,Infants, Premature,Infants, Preterm,Premature Infant,Prematurity, Neonatal,Preterm Infant
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016232 Endothelins 21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, ENDOTHELIN-1; ENDOTHELIN-2; and ENDOTHELIN-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profiles of the pharmacological activities are considerably different among the three isopeptides. Endothelium-Derived Vasoconstrictor Factors,Endothelin,Vasoconstrictor Factors, Endothelium-Derived

Related Publications

T Kojima, and Y Isozaki-Fukuda, and M Takedatsu, and Y Hirata, and Y Kobayashi
August 1989, Journal of developmental physiology,
T Kojima, and Y Isozaki-Fukuda, and M Takedatsu, and Y Hirata, and Y Kobayashi
November 1993, Japanese heart journal,
T Kojima, and Y Isozaki-Fukuda, and M Takedatsu, and Y Hirata, and Y Kobayashi
October 1991, Casopis lekaru ceskych,
T Kojima, and Y Isozaki-Fukuda, and M Takedatsu, and Y Hirata, and Y Kobayashi
January 1994, Transplant international : official journal of the European Society for Organ Transplantation,
T Kojima, and Y Isozaki-Fukuda, and M Takedatsu, and Y Hirata, and Y Kobayashi
March 1987, Endocrinology and metabolism clinics of North America,
T Kojima, and Y Isozaki-Fukuda, and M Takedatsu, and Y Hirata, and Y Kobayashi
March 1996, Metabolism: clinical and experimental,
T Kojima, and Y Isozaki-Fukuda, and M Takedatsu, and Y Hirata, and Y Kobayashi
November 1984, Biochemical and biophysical research communications,
T Kojima, and Y Isozaki-Fukuda, and M Takedatsu, and Y Hirata, and Y Kobayashi
November 1988, American heart journal,
T Kojima, and Y Isozaki-Fukuda, and M Takedatsu, and Y Hirata, and Y Kobayashi
August 1991, The Thoracic and cardiovascular surgeon,
T Kojima, and Y Isozaki-Fukuda, and M Takedatsu, and Y Hirata, and Y Kobayashi
December 1990, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!